Newsroom
From the Program Lead: The progress made over the last year
In a short video interview, Dr. Benjamin Dälken, Senior Director, Global Program Lead Immunology & Global Health at Merck, and Global Program Lead of the Pediatric Praziquantel Consortium, reflects on the progress made over the last year for the Consortium.
In particular, Benjamin talks about the clinical strategy and development plan and summarizes the key steps moving forward.